Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: cytokine and gene therapy with IL-2 and GM-CSF

MIKYŠKOVÁ, R., INDROVÁ, M., ŠÍMOVÁ, J., JANDLOVÁ, T., BIEBLOVÁ, J., JINOCH, P., BUBENÍK, J., VONKA, V. Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: cytokine and gene therapy with IL-2 and GM-CSF. International Journal of Oncology. 2004, 24(1), 161-167. ISSN 1019-6439. E-ISSN 1791-2423.